Fact-checked by Grok 2 weeks ago

Paracentesis

Paracentesis is a minimally invasive that involves the insertion of a needle and into the to remove excess fluid accumulation known as from the . This fluid buildup occurs between the layers of the , the membrane lining the , and is most commonly caused by liver , though it can also result from conditions such as cancer, infections, , or . The procedure serves both diagnostic and therapeutic purposes: diagnostically, a small sample of fluid (typically 25-30 mL) is analyzed to identify underlying causes, such as or , through tests including cell counts, protein levels, and the (SAAG). Therapeutically, larger volumes—up to 5 liters or more in cases of large-volume paracentesis (LVP)—are drained to alleviate symptoms like , discomfort, , and reduced mobility associated with tense . It is indicated for new-onset , suspected , or respiratory compromise due to fluid pressure, and is particularly vital in patients with , where affects up to 50% of cases and carries significant mortality risk. Performed at the bedside or in an outpatient setting under and often with guidance for safety, paracentesis typically takes 20-45 minutes and involves positioning the patient , sterilizing the lower abdominal quadrant, numbing the site with lidocaine, and using a Z-track insertion technique to minimize leakage. Healthcare providers such as gastroenterologists or interventional radiologists conduct the using specialized kits including 18-20 needles, catheters, and drainage bags, with intravenous recommended after LVP exceeding 5 liters to prevent circulatory dysfunction. Although generally safe with low complication rates, potential risks include , , fluid leakage, bowel perforation, or , particularly in patients with or on blood thinners; absolute contraindications encompass acute surgical or severe bleeding disorders. Post-procedure recovery involves 24 hours of rest, monitoring for and signs of , wound care to address any seepage, and lifestyle measures like a low-sodium to manage recurrent , which may necessitate repeated procedures or indwelling catheters.

Overview

Definition and Types

Paracentesis is a that involves the percutaneous insertion of a needle or into the to aspirate fluid, primarily ascitic fluid, which accumulates abnormally due to conditions such as liver cirrhosis, , or . The term derives from the Greek "parakentein," meaning "to pierce at the side," reflecting its historical roots in targeting fluid buildup in the . There are two main types of paracentesis: diagnostic and therapeutic. Diagnostic paracentesis entails the removal of a small volume of ascitic fluid, typically 25 to 50 mL, for analysis to determine the underlying cause of or to exclude infections such as . In contrast, therapeutic paracentesis, often termed large-volume paracentesis (LVP), involves extracting larger quantities of fluid, generally exceeding 5 liters, to provide symptomatic relief in cases of tense . The primary purposes of paracentesis are both diagnostic and palliative. Therapeutically, it alleviates intra-abdominal pressure that contributes to symptoms like dyspnea, , and early , thereby improving patient comfort and . Diagnostically, it facilitates the identification of etiologies such as or through fluid examination. The has been used since antiquity for management, with describing it around 400 BCE, and underwent significant modern refinements in the 20th century, including the integration of guidance for enhanced safety and precision. It is commonly performed for new-onset or suspected .

Epidemiology

Paracentesis is most commonly performed to address , a condition predominantly caused by , which accounts for 80-85% of all cases. Approximately 50% of patients diagnosed with develop within 10 years, marking a critical progression to decompensated . Other etiologies include (10%), (3%), and infections such as tuberculous peritonitis, though these are less frequent. The global burden of is disproportionately higher in regions with elevated rates of , particularly those driven by alcohol consumption or like and C. The clinical significance of ascites in cirrhosis is underscored by its impact on patient outcomes, with a 1-year mortality rate of 20% among affected individuals, compared to 7% in those with compensated cirrhosis without ascites. In cases of suspected spontaneous bacterial peritonitis (SBP), a common complication necessitating diagnostic paracentesis, delaying the procedure beyond 12 hours from admission increases in-hospital mortality by 2.7-fold, even after adjusting for factors like MELD score and renal dysfunction. These statistics highlight the procedure's role in timely diagnosis and management to mitigate poor prognosis. Recent trends as of reflect an expansion in the performance of paracentesis by advanced practice providers (APPs), such as nurse practitioners and physician assistants, particularly in and outpatient settings, driven by growing procedure volumes and reimbursement opportunities. This shift supports broader access to therapeutic paracentesis for refractory amid rising demand.

Indications and Contraindications

Indications

Paracentesis is indicated for both diagnostic and therapeutic purposes in patients with , particularly those associated with . Diagnostic paracentesis is recommended for all patients presenting with new-onset of unknown origin to determine the underlying etiology, such as via (SAAG) analysis. It is also essential in cases of suspected (SBP), including clinical features like fever, , or in cirrhotic patients, where ascitic fluid analysis for polymorphonuclear leukocyte count (>250 cells/mm³) and culture confirms the . Guidelines strongly advise performing diagnostic paracentesis on admission for all hospitalized patients with and , even in the absence of overt symptoms, to monitor for complications like SBP and assess disease progression. This is particularly relevant for evaluating potential malignancy through cytology or via acid-fast bacilli staining and levels in ascitic fluid when these etiologies are suspected. Therapeutic paracentesis, often as large-volume paracentesis (LVP) involving removal of more than 5 liters of fluid, is indicated for symptomatic tense unresponsive to diuretics, providing rapid symptom relief and improving . It is also recommended for refractory in end-stage , including scenarios of respiratory compromise due to diaphragmatic elevation, and as a palliative measure to alleviate discomfort in patients not eligible for . The alfapump system, approved by the US FDA in December 2024, is used for managing recurrent or refractory due to liver as an outpatient option; it continuously transfers ascitic fluid from the to the , reducing the need for repeated LVPs.

Contraindications

Paracentesis has few absolute contraindications, which represent conditions where the risks of the procedure significantly outweigh any potential benefits. These include an acute surgical abdomen, such as bowel requiring , () that is unresponsive to correction, and overt accompanied by systemic . Relative contraindications are more common and often can be managed or mitigated, though they warrant careful evaluation. Uncorrectable , such as a platelet count below 20 × 10³/μL or an international normalized (INR) greater than 2.0, is a key relative ; however, the overall bleeding risk associated with paracentesis remains low, at approximately 0.2-0.6%, even in patients with mild to moderate .30407-5/fulltext) Other relative contraindications include , due to potential risks to the ; bowel distention from or obstruction; and site-specific issues such as at the entry point, enlarged organs (), or vascular abnormalities like prominent vessels. Precautions are essential to minimize risks in patients with relative contraindications. Correctable coagulopathies should be addressed prior to the procedure, for example, through for severe or administration of or for elevated INR. The procedure should be avoided at sites with multiple prior paracenteses due to the risk of adhesions and bowel adherence. Ultrasound guidance can help identify safe entry sites to avoid relative risks such as vascular structures or organ enlargement. Given the low overall complication rate, guidelines support proceeding with paracentesis in most cases of relative contraindications after appropriate precautions.

Procedure

Preparation and Equipment

Patient preparation for paracentesis begins with obtaining , during which the clinician explains the procedure's purpose, potential risks such as or , benefits including symptom , and alternatives like medical management. The patient is positioned or semi-recumbent at a 30- to 45-degree angle to facilitate fluid pooling in the lower quadrants, with the emptied beforehand to reduce risk. , including and , are monitored before, during, and after the procedure to detect complications like . Prophylactic antibiotics are not routinely administered unless is suspected, in which case a third-generation may be given empirically if ascitic fluid count exceeds 250 cells/mm³. Coagulation status is assessed via international normalized ratio (INR) and platelet count, but routine correction of is unnecessary even with INR up to 8.7 or platelets below 20 × 10³/μL, as the bleeding risk remains low; may be considered only if counts are under 20 × 10³/μL. For large-volume paracentesis (LVP) involving removal of more than 5 L of fluid, intravenous is planned at 6 to 8 g of 25% albumin per liter removed to prevent post-paracentesis circulatory dysfunction. The procedure can be performed in a bedside, outpatient , or suite setting, with no fasting required. is often used briefly to identify and mark the optimal entry site in a safe fluid pocket deeper than 2 cm. Essential equipment includes a sterile preparation kit with or solution, sterile drapes, and gloves; 1% lidocaine (typically 5 to 10 mL) with 25- or 27-gauge needles for ; an 18- to 20-gauge access needle for diagnostic paracentesis; a catheter-over-needle system or 8- to 15-French angiocatheter for LVP; drainage tubing connected to a collection or vacuum bottles with up to 10 L capacity, or wall if available; and sample collection tubes (e.g., red-top, purple-top EDTA, and bottles) for 25 to 30 mL of diagnostic fluid. An machine with a low-frequency curvilinear (3.5 MHz) and sterile is recommended for guidance. Additional items such as 5- to 60-mL syringes, a #11 , , and adhesive dressings ensure sterile technique and secure the site post-procedure.

Ultrasound Guidance

Ultrasound guidance in paracentesis serves to identify the optimal site for needle insertion by locating the deepest pocket of ascitic fluid, typically requiring a depth of at least 3 cm to ensure safe access, while avoiding interposed bowel, blood vessels, or solid organs such as the liver or . This approach enhances procedural safety, particularly in patients with or small-volume , where physical landmarks may be unreliable. The technique involves using a curvilinear probe with a of 3.5-5 MHz for initial detection due to its deeper penetration, or a linear (8-12 MHz) for superficial and real-time needle if needed. Scanning begins in the lower abdominal quadrants lateral to the , with the left side preferred to minimize from epigastric vessels; the is applied in sagittal and transverse planes to confirm depth and exclude vascular structures using color Doppler. The is marked 2-3 cm below the umbilicus at the site of maximal accumulation, either via static pre-procedure marking or dynamic guidance during needle insertion. Guidelines from the Society of Hospital Medicine strongly recommend guidance for all paracentesis procedures to reduce serious complications, such as , with evidence from large cohort studies showing a 68% lower odds of (OR 0.32, 95% CI 0.25-0.41) compared to blind techniques. Complication rates drop from 4.7% without guidance to 1.4% with it (OR 0.349), and success rates improve to 95-100% versus 61% for landmark-based methods. Dynamic guidance is particularly beneficial for visualizing the needle in challenging cases, though static marking suffices for larger fluid volumes in experienced operators. Limitations include limited availability of ultrasound equipment in some settings, which may necessitate reliance on clinical expertise for site selection. Additionally, while real-time guidance offers superior precision, evidence for its incremental benefit over static methods remains limited, and proficiency requires dedicated .

Technique

Paracentesis is typically performed with the patient in a semi-recumbent position at 30 to 45 degrees to facilitate pooling in the lower and minimize discomfort. The preferred site for insertion is the left lower quadrant, approximately 2 medial and superior to the , lateral to the , to avoid major vessels and bowel loops. This location is selected after percussion or confirmation of a pocket greater than 2 deep, with the skin marked using a . The Z-track is employed by displacing the skin caudally prior to insertion to create a tortuous path that minimizes post-procedure leakage. After ensuring the is empty via voiding or catheterization, the area is prepared with or solution and sterile draping applied to create a working field. is achieved by raising a wheal with 1% lidocaine using a 25-gauge needle, followed by deeper infiltration along the planned tract to the using a 22-gauge needle, administering 5 to 10 mL total to anesthetize the , which may extend 2 to 4 cm in depth depending on habitus. A small nick in the is made with a No. 11 blade to facilitate entry. For insertion, an 18- to 20-gauge over-the-needle or angiocatheter is advanced to the skin in 5-mm increments while applying with a to aspirate; entry into the is confirmed by the return of non-pulsatile ascitic fluid, at which point the needle is withdrawn and the advanced 2 to 5 mm further. In the Z-track , the skin is held displaced during insertion and released afterward to seal the tract. For diagnostic paracentesis, a single puncture suffices to aspirate 25 to 50 mL of fluid directly into syringes for . If loculated is suspected, multiple punctures may be required at different sites. The procedure is terminated immediately if resistance is encountered, frank blood is aspirated, or the patient reports significant pain, indicating potential organ injury. For therapeutic large-volume paracentesis (LVP), the is connected via tubing to a collection bottle or drainage bag using a three-way stopcock, allowing controlled by or passive flow at a rate of 300 to 500 mL per minute to avoid rapid hemodynamic shifts. is halted once symptoms resolve. Intravenous (6 to 8 g per liter removed) is recommended if more than 5 L of fluid is removed to prevent circulatory dysfunction. The is then removed, and the site covered with a sterile and pressure applied for 5 minutes to achieve . Variations include blind insertion in experienced hands for straightforward cases, though guidance is standard to enhance safety; for refractory , indwelling catheters like the Tenckhoff may be used for repeated access. The procedure duration is typically 15 to 30 minutes for diagnostic taps and 30 to 60 minutes for LVP, with continuous vital sign monitoring for or throughout.

Fluid Analysis

Sample Collection

During diagnostic paracentesis, an initial volume of 25 to 30 mL of ascitic fluid is collected for and divided into aliquots based on the suspected . Typical distribution includes approximately 10 mL for cell count and , 5 mL for total protein and (SAAG) determination, and additional volume (ideally ≥80 mL if available) for cytology when is suspected to enhance diagnostic yield. The fluid is obtained by attaching a 60-mL to a three-way stopcock connected to the paracentesis , allowing controlled and direct transfer into collection tubes or vials while minimizing air bubble introduction, which could compromise sample integrity. Cultures require immediate transport to the at , with on-site of at least 10 mL into each of two bottles recommended when (SBP) is suspected to maximize sensitivity. Special considerations include collecting separate aliquots for targeted tests, such as in cases of suspected or triglycerides for evaluating , using appropriate containers like sterile pots for biochemistry or serum-separating tubes. If processing is delayed, non-culture samples should be refrigerated at 4°C, while cytology specimens must avoid to prevent interference with cellular analysis.

Laboratory Tests and Interpretation

Laboratory analysis of ascitic fluid obtained via paracentesis is essential for diagnosing the underlying cause of and identifying complications such as . The gross appearance of the fluid provides initial clues: clear fluid is typical of uncomplicated cirrhotic , cloudy appearance suggests , milky fluid indicates chylous , and fluid may result from during the procedure or underlying . The primary tests include total nucleated cell count with differential, , , total protein, and levels to calculate the (SAAG). (SBP) is diagnosed when the in the ascitic fluid is ≥250 cells/mm³, even in the absence of symptoms. and , with fluid inoculated directly into bottles at the bedside, identify the causative organism in approximately 80% of SBP cases, guiding . The is calculated as minus ascitic fluid ; a value ≥1.1 g/dL indicates with high accuracy. Additional tests are selected based on clinical suspicion. Cytology examines for malignant cells in cases of suspected . (LDH) and levels help identify secondary causes: elevated LDH (> upper limit of normal for ) suggests exudative processes, while high points to pancreatic or gastrointestinal origins. levels >200 mg/dL confirm chylous , often due to lymphatic disruption. Interpretation of results differentiates ascites etiologies. A high (≥1.1 g/dL) with low total protein (<2.5 g/dL) strongly suggests cirrhosis-related portal hypertension. Conversely, a low (<1.1 g/dL) with high total protein (>2.5 g/dL) indicates non-portal hypertensive causes, such as . Culture-negative neutrocytic ascites, defined as neutrophil count ≥250 cells/mm³ with negative cultures, represents a variant of SBP and is managed similarly. These findings inform clinical management. For SBP, empirical antibiotics such as are initiated immediately, with adjustments based on culture results; resolution is confirmed by a drop in neutrophils to <250 cells/mm³. In endemic areas, additional testing for tuberculosis or fungi may be warranted if initial cultures are negative.

Complications

Types and Risks

Complications of paracentesis are generally uncommon, with overall rates reported between 1% and 2% across large prospective studies. These can be categorized as common (incidence 1-5%) or serious and rare (incidence <1%), with the majority being self-limited or manageable. Persistent ascitic fluid leak at the puncture site occurs in 0.8-1.7% of procedures and is more likely in patients with low serum albumin or tense ascites. Abdominal pain, often mild and transient, affects up to 5% of patients immediately post-procedure. Minor bleeding or hematoma formation at the site is reported in approximately 1% of cases, typically resolving without intervention. Serious complications occur in fewer than 1% of paracenteses but can be life-threatening. Bowel perforation, with an incidence of 0.3-0.5%, is a rare but critical event often linked to underlying adhesions or improper site selection. Vascular injury, leading to significant intra-abdominal hemorrhage, shares a similar low incidence of <1%. Iatrogenic infection, including secondary peritonitis, develops in 0.1-0.5% of procedures, based on data from over 600 cases showing three infections total. Clinically significant hypotension and post-paracentesis circulatory dysfunction (PPCD) after large-volume paracentesis (>5 L removed) without occur in approximately 15-20% of patients (subclinical PRA-based incidence up to 80%). PPCD is defined as a >50% increase in from baseline, measured on day 6 post-procedure, reaching levels >4 ng/mL/h. Certain risk factors elevate complication rates. Large-volume paracentesis without prophylaxis significantly heightens the risk of renal failure (approximately 10-20% without vs. <10% with ). or intra-abdominal adhesions increase the likelihood of bowel by complicating needle navigation. The overall mortality attributable to the procedure remains low at <0.2%, with fatal outcomes primarily tied to severe hemorrhage or in high-risk cohorts.

Prevention

Routine use of ultrasound guidance during paracentesis is recommended to identify optimal fluid pockets and reduce the risk of adverse events such as organ injury (reducing overall complications from 4.7% to 1.4%). Adherence to strict sterile technique, including skin preparation with or , sterile gloves, and drapes, is essential to minimize the risk of . Prior to the , coagulopathy should be assessed and corrected if significant, such as through for counts below 20 × 10³/μL, although routine correction is not required for mild elevations in INR or platelets. For therapeutic paracentesis, fluid removal should be limited to less than 5 L without supplementation to avoid circulatory instability; for larger volumes, of 6-8 g of 25% per liter removed (up to a maximum of 200 g) is advised to prevent post-paracentesis circulatory dysfunction (PPCD).

Management

Post-procedure, patients should be monitored closely for , including and pulse every 15 minutes for the first 2 hours, to detect early signs of or other hemodynamic changes. Leaks at the puncture site can be managed by applying a single skin suture or manual . In cases of suspected infection such as , prompt administration of broad-spectrum antibiotics, such as third-generation cephalosporins, is indicated. requires immediate fluid , often with infusion if associated with large-volume paracentesis. , though rare, necessitates urgent surgical consultation for repair. In patients with (SBP), albumin administration at 1.5 g/kg on day 1 followed by 1 g/kg on day 3, alongside antibiotics, significantly reduces the incidence of (10% versus 33%) and mortality (10% versus 29%).

Post-Care

Following paracentesis, patients should undergo bed rest for 1-2 hours and observation for 4-6 hours to monitor for delayed complications. They should be advised to report any fever, increasing , or other concerning symptoms promptly to facilitate early .

References

  1. [1]
    Paracentesis: What It Is, Procedure & Complications - Cleveland Clinic
    Paracentesis is a procedure that removes fluid buildup inside your abdomen, called ascites. It can be used to treat ascites and diagnose the cause.
  2. [2]
    Paracentesis - StatPearls - NCBI Bookshelf - NIH
    Sep 16, 2025 · Paracentesis is a procedure performed in patients with ascites, in which a needle is inserted into the peritoneal cavity to obtain or remove ...
  3. [3]
    Diagnostic and therapeutic abdominal paracentesis - PMC
    Nov 30, 2022 · Paracentesis is regularly performed at the bedside under local anaesthetic, with minimal discomfort, by a variety of health care professionals.
  4. [4]
    Historical Aspects of Ascites and the Hepatorenal Syndrome - PMC
    Oct 29, 2021 · The Early Days of Paracentesis. Ascites or abdominal dropsy has been known since antiquity, according to descriptions in The Papyrus Ebers from ...
  5. [5]
    Ascites (common causes) | Diagnosaurus - Unbound Medicine
    Cirrhosis (80-85%) · Malignancy (10%) · Congestive heart failure (3%) · Tuberculous peritonitis · Dialysis-related · Bile or pancreatic ascites · Lymphatic tear ( ...
  6. [6]
    Guidelines on the management of ascites in cirrhosis - Gut
    Ascites is a major complication of cirrhosis,1 occurring in 50% of patients over 10 years of follow up.2 The development of ascites is an important landmark in ...
  7. [7]
    Guidelines on the management of ascites in cirrhosis - PMC
    Ascites is a major complication of cirrhosis, occurring in 50% of patients over 10 years of follow up. The development of ascites is an important landmark in ...
  8. [8]
    The global, regional, and national burden of cirrhosis by cause in ...
    Jan 22, 2020 · The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of ...
  9. [9]
    Management of patients with decompensated cirrhosis - PMC - NIH
    ... patients per year and is associated with a high mortality (one-year mortality in compensated cirrhosis is 7% compared with 20% following liver decompensation).
  10. [10]
    Delayed paracentesis is associated with increased in-hospital ...
    Conclusions: Hospitalized patients with SBP who received DP had a 2.7-fold increased risk of mortality adjusting for MELD score and renal dysfunction.
  11. [11]
    Growth in Thoracentesis and Paracentesis Performed by Radiology ...
    The purpose of this study is to analyze the trends in physician and APP volumes and reimbursement for paracentesis and thoracentesis after the revision of ...
  12. [12]
    Utilizing advanced practice providers in the paracentesis ... - PubMed
    Mar 8, 2022 · One such strategy involves the employment of advanced practice providers to perform certain procedures.
  13. [13]
    Diagnosis, Evaluation, and Management of Ascites, Spontaneous ...
    May 3, 2021 · This AASLD Guidance provides a data-supported approach to the management of ascites and HRS. It differs from the AASLD Guidelines, which are ...
  14. [14]
    Guidelines on the management of ascites in cirrhosis - PMC
    The aim of this guideline is to review and summarise the evidence that guides clinical diagnosis and management of ascites in patients with cirrhosis.
  15. [15]
    Automated low-flow ascites pump for the treatment of cirrhotic ...
    The automated low-flow ascites pump (alfapump) is a subcutaneously-implanted novel battery-driven device that pumps ascitic fluid from the peritoneal cavity ...
  16. [16]
    Paracentesis: Background, Indications, Contraindications
    Jul 11, 2024 · Paracentesis is a procedure in which a needle or catheter is inserted into the peritoneal cavity to obtain ascitic fluid for diagnostic or therapeutic purposes.Background · Indications · Contraindications · Technical Considerations
  17. [17]
    How To Do Paracentesis - Gastrointestinal Disorders - Merck Manuals
    Contraindications to Paracentesis · Severe, uncorrectable disorders of blood coagulation · Intestinal obstruction with bowel distention (unless an area of ...Missing: sepsis | Show results with:sepsis
  18. [18]
    Ultrasound-Guided Paracentesis | New England Journal of Medicine
    Sep 3, 2025 · Diagnostic paracentesis involves the use of fine-needle aspiration to establish the causes of nascent ascites or to rule out infections such as ...
  19. [19]
    10. Paracentesis | Hospital Handbook
    Worsening renal failure for therapeutic paracentesis. Distended bowel, ileus, bowel obstruction, or pregnancy (in the absence of ultrasound as these conditions ...
  20. [20]
    Paracentesis | Sonoguide - ACEP
    Nov 29, 2021 · This procedure is invasive and presents a risk for complications with high morbidity such as bowel perforation and infection.1,2; Ultrasound ...
  21. [21]
    Point-of-Care Ultrasonography - PoCUS Scan: Ascities
    It is generally accepted that a minimum depth of at least 3 cm of fluid is needed to perform the procedure safely. If adhesions are present, the movement of the ...Missing: deepest | Show results with:deepest
  22. [22]
    Recommendations on the Use of Ultrasound Guidance for Adult ...
    In this document, ultrasound-guided paracentesis refers to the use of static ultrasound guidance to mark a needle insertion site immediately prior to performing ...
  23. [23]
    Chapter 19. Ultrasound for Paracentesis - AccessAnesthesiology
    Curvilinear Probe with a Frequency of 3.5–5.0 MHz ... The initial probe for detection of fluid should be a large footprint curvilinear probe in the 3.5–5.0 MHz ...
  24. [24]
    Ultrasound guidance decreases complications and improves the ...
    Feb 1, 2013 · The data indicate that ultrasound guidance is associated with decreased risk of pneumothorax with thoracentesis and of bleeding complications with paracentesis.
  25. [25]
    Paracentesis Technique - Medscape Reference
    Jul 11, 2024 · The authors recommend alternating injection and intermittent aspiration down the tract until ascitic fluid is noticed in the syringe.
  26. [26]
    Paracentesis on Admission for Cirrhosis with Ascites - AASLD
    Oct 31, 2025 · ... 2.7- fold increased mortality risk. In a group of 239 patients with SBP, those who had an early paracentesis <12 hours from admission had ...
  27. [27]
    Collection and processing of effusion fluids for cytopathologic ...
    If the specimen cannot be sent immediately to the laboratory or cannot be processed soon after submission, it may be stored in a refrigerator at 4°C; it should ...<|control11|><|separator|>
  28. [28]
    Differential diagnosis of ascites: etiologies, ascitic fluid analysis ...
    Dec 20, 2023 · The initial evaluation of the gross appearance of ascitic fluid provide useful diagnostic information. Uncomplicated cirrhotic ascites is ...
  29. [29]
    Ascites and spontaneous bacterial peritonitis - NIH
    [77] When the PMN count of the ascitic fluid is greater than 250 cells/mm3, the diagnosis of SBP can be made.
  30. [30]
    Spontaneous Bacterial Peritonitis: A Review of Treatment Options
    Of all the information gleaned from the ascitic fluid cytologic “tap,” the neutrophil count remains the best test for making a presumptive diagnosis of SBP.Clinical Presentation And... · Ascitic Fluid Analysis Via... · Antibiotic Therapy
  31. [31]
    Ascitic Fluid Analysis in the Differential Diagnosis of Ascites - NIH
    SBP is defined by the presence of neutrophil cells greater than or equal to 250/μL or a positive bacterial culture in the ascitic fluid without evidence of an ...
  32. [32]
    [PDF] the diagnostic approach and current management of chylous ascites
    Ascitic fluid should be sent for cytology, cell count, Gram's stain, culture, total protein concentration, albumin, LDH, glucose, triglyceride and amylase.
  33. [33]
    Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment
    Dec 4, 2017 · Diagnosis is primarily based on paracentesis, with a characteristic milky creamy gross fluid appearance and elevated fluid triglyceride levels.
  34. [34]
    Unexplained ascites - PMC - NIH
    When the SAAG is ≥1.1 g/dL and the total protein in the ascites is low (<2.5 g/dL), the cause of the ascites is undoubtedly cirrhosis and portal hypertension.Missing: interpretation | Show results with:interpretation
  35. [35]
    [PDF] Recognition and Management of Spontaneous Bacterial Peritonitis
    Sep 21, 2025 · For a diagnostic paracentesis, ascitic fluid should be sent for cell count and differential analysis and should be directly inoculated into ...
  36. [36]
    EASL clinical practice guidelines on the management of ascites ...
    The initial evaluation of a patient with ascites should include history, physical examination, abdominal ultrasound, and laboratory assessment of liver function ...
  37. [37]
    Post-paracentesis Ascitic Fluid Leak in Patients with Cirrhosis of ...
    The ascitic fluid leak can develop after paracentesis in patients with cirrhosis leading to significant morbidity if persistent. We aimed to study the incidence ...
  38. [38]
  39. [39]
    Hemorrhagic Complications of Paracentesis: A Systematic Review ...
    Large volume paracentesis (LVP) involves removal of as much ascitic fluid as possible to relieve symptoms of a tense abdomen and dyspnea.<|control11|><|separator|>
  40. [40]
    Paracentesis Complications - POCUS Pro and Proceduralist.org
    Bowel perforation. Occurs in less than 0.5%5; Prevention. Avoid surgical scars ... Risk of complications after abdominal paracentesis in cirrhotic patients: a ...
  41. [41]
    Paracentesis-induced circulatory dysfunction: are there albumin ...
    Aug 5, 2020 · When patients were given β blockers, the prevalence of PICD was 80%. After the withdrawal of β blockers, the prevalence of PICD dropped to 10%.
  42. [42]
    Low dose albumin for the prevention of renal impairment following ...
    This study suggests that 4 grams of albumin per litre of ascitic fluid drained is effective in preventing the PICD related renal impairment following large ...
  43. [43]
    Perforation of the ascending colon during implantation of an ...
    Oct 16, 2020 · Patients with septated ascites and intraperitoneal adhesions are at potential higher risk of bowel perforation during implantation of an ...